Provider
Employees will have access to clinical content and more than 900 U.S. clinics that specialize in fertility, urology and menopause.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
HIMSS25
AI tools can personalize patients' searches for providers, but Kyruus Health's Gen Conlin believes nurse informaticists' ability to ensure tool accessibility and accuracy are vital to ensuring patients find the right care.
Selected early versions will be slated for real-world deployment.
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Patients will get same-day delivery and access to treatments like GLP-1s and hormone therapies.
Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.
HIMSS25
With healthcare spending, particularly for Medicare Advantage, under scrutiny, 1upHealth's Dr. Don Rucker says AI-ready, open API platforms that can integrate and analyze disparate data are needed to inform care and control costs.